Abstract:(T)o develop a rat model of type 2 diabetic mellitus that simulated the common manifestation of the metabolic abnormalities and resembled the natural history of a certain type 2 diabetes in human population, male Sprague-Dawley rats (4 months old) were injected with low-dose (15 mg/kg) STZ after high fat diet (30% of calories as fat) for two months (L-STZ/2HF). The functional and histochemical changes in the pancreatic islets were examined. Insulin-glucose tolerance test, islet immunohistochemistry and other corresponding tests were performed and the data in L-STZ/2HF group were compared with that of other groups, such as the model of type 1 diabetes (given 50 mg/kg STZ) and the model of obesity (high fat diet). The body weight of rats in the group of rats given 15 mg/kg STZ after high fat diet for two months increased significantly more than that of rats in the group of rats given 50 mg/kg STZ (the model of type I diabetes) (595 33 g vs. 352 +/- 32 g, vs g, p<O. 05). Fast blood glucose levels for L-STZ/2HF group were 16.92 +/- 1.68 mmol/l, versus 5.17 +/- 0.55 mmol/l in normal control and 5.59 +/- 0.61 mmol/l in rats given high fat diet only. Corresponding values for fast serum insulin were 0.66 +/- 0.15 mug/ml, 0.52 +/- 0.13 mug/ml, 0.29 +/- 0.11 ng/ml, respectively. Rats of type 2 ldiabetes (L-STZ12HF) had elevated levels of triglyceride (TG, 3.82 +/- 0.88 mmol/l), and cholesterol(Ch, 2.38 +/- 0.55 mmoll/l) compared with control (0.95 +/- 0.15 mmol/l and 1.31 +/- 0.3 mmolll, respectively) (p < 0.05). The islet morphology as examined by immunocytochemistry using insulin antibodies in the L-STZ12HF group was affected and quantitative analysis showed the islet insulin content was higher than that of rats with type 1 diabetes (P < 0.05). We concluded that the new rat model of type 2 diabetes established with conjunctive treatment of low dose of STZ and high fat diet was characterized by hyperglycemia and light impaired insulin secretion function accompanied by insulin resistance, which resembles the clinical manifestation of type 2 diabetes. Such a model, easily attainable and inexpensive, would help further elucidation of the underlying mechanisms of diabetes and its complications.

Streptozotocin-induced morphological changes in rat lungs

Expression Changes of Transforming Growth Factor-Beta1 and Thrombospondin-1 in Cavernous Tissues of Diabetic Rats.

Streptozotocin Directly Impairs Cardiac Contractile Function in Isolated Ventricular Myocytes Via a P38 Map Kinase-Dependent Oxidative Stress Mechanism.

Influence of Streptozocin's Dose on Inductive Effect of Diabetes in C57BL/6J Mice

Experimental Research of Oxidative Stress in Diabetic Complication

Histomorphometry Changes and Decreased Reactivity to Angiotensin II in the Ileum and Colon of Streptozotocin-Induced Diabetic Rats

Morphological changes in diabetic rat’s retina induced by streptozotocin

Streptozotocin (STZ)-Induced Diabetes Affects Tissue Trace Element Content in Rats in a Dose-Dependent Manner

Streptozotocin-induced deficits in sex behavior and neuroendocrine function in male rats

Expressions of adiponectin receptors in lung tissue of type 1 and type 2 diabetic rats

Streptozotocin-induced dynamic metabonomic changes in rat biofluids.

Study on the Diabetic Model Induced by Streptozocin in Wistar Rats

Changes of TGF - β1 , Vimentin and Desmin Gene Expression in the Renal Cortex of Streptozotocin - induced Diabetic Rats

Streptozotocin-Induced Type 1 and 2 Diabetes Mellitus Mouse Models Show Different Functional, Cellular and Molecular Patterns of Diabetic Cardiomyopathy

Streptozotocin‐Induced Diabetic Models in Mice and Rats

Oxidative stress and inflammatory markers in streptozotocin-induced acute and subacute toxicity response

Streptozotocin-induced type 1 and 2 diabetes in rodents: a model for studying diabetic cardiac autonomic neuropathy

Effects of different doses of streptozotocin on islet structure and main cell component in mice

The rat model of type 2 diabetic mellitus and its glycometabolism characters.

A study on establishment of low-dose Streptozotocin-induced Gestational Diabetes in rats

Study on the Optimization and Stability of Single-dose Streptozotocin-induced Diabetic Modelling in Rats